PubMed Health⌕ Search

PubMed · 11849098

From clusters to ionic complexes: structurally characterized thallium titanium double alkoxides.

Abstract

A series of sterically varied titanium alkoxides [[Ti(OR)(4)](n)(), n = 4, OR = OCH(2)CH(3) (OEt); n = 1, OCH(CH(3))(2) (OPr(i)); n = 2, OCH(2)C(CH(3))(3) (ONep); n = 1, OC(6)H(3)(CH(3))(2)-2,6 (DMP)] were reacted with a series of thallium alkoxides [[Tl(OR)](x) (x = 4, OR = OEt, ONep; n = infinity, DMP)]. The resultant products of the [Tl(mu(3)-OEt)](4)-modified [Ti(OR)(4)](n)() (OR = OEt, OPr(i), ONep) were found by X-ray analysis to be Tl(4)Ti(2)(mu-O)(mu(3)-OEt)(8)(OEt)(2) (1), Tl(4)Ti(2)(mu-O)(mu(3)-OPr(i))(5)(mu(3)-OEt)(3)(OEt)(2) (2), and TlTi(2)(mu(3)-OEt)(2)(mu-OEt)(mu-ONep)(2)(ONep)(4) (3), respectively. The reaction of [Tl(mu(3)-OEt)](4), 12HOEt, and 4[Ti(mu-ONep)ONep)(3)](2) to generate 3 in a higher yield resulted in the isolation of TlTi(2)(mu(3)-OEt)(mu(3)-ONep)(mu-OEt)(mu-ONep)(2)(ONep)(4) (4). Compounds 1 and 2 possess an octahedral (Oh) arrangement of two Ti and four Tl metal atoms around a mu-O central oxide atom (the Tl-O distance is too long to be considered a bond). For both compounds, each Ti atom adopts a distorted Oh geometry with one terminal OEt ligand. The Tl atoms are formally 4-coordinated, adopting a distorted pyramidal geometry using four mu(3)-OR (OR = OEt or OPr(i)) ligands to complete their coordination sphere. The Tl atoms reside approximately 1.4 A below the basal plane of oxygens. In contrast to these structures, both 3 and 4 utilize ONep ligands and display reduced oligomerization yielding trinuclear complexes without oxo formation. The two Ti cations are Oh, and the single Tl cation is in a formal distorted pyramidal (PYD) arrangement. If the lone pair of the Tl cations are considered in the geometry, each Tl adopts a square base pyramidal geometry. Two terminal ONep ligands are bound to each Ti with the remainder of the molecule consisting of mu(3)- and mu-ONep ligands. The reaction of [Tl(mu(3)-ONep)](4) with two equivalents of [Ti(mu-ONep)(ONep)(3)](2) also led to the isolation of the homoleptic trinuclear complex TlTi(2)(mu(3)-ONep)(2)(mu-ONep)(3)(ONep)(4) (5) which is analogous in structure to the mixed ligand species of 3 and 4. Each Ti is Oh coordinated with six ONep ligands, and the single Tl is PYD bound by ONep ligands. A further increase in the steric bulk of the pendant ligands, using [Tl(mu-DMP)](infinity) and [Ti(mu-ONep)(ONep)(3)](2), resulted in a further decrease in the nuclearity yielding the dinuclear species TlTi(mu-DMP)(mu-ONep)(DMP)(ONep)(2) (6). For 6, the two metals are bound by a mu-ONep and a mu-DMP ligand. The Tl metal center was solved in a bent geometry while the Ti adopted a distorted trigonal bipyramidal (TBP) geometry using three ONep and two DMP ligands to fill its coordination sphere. Further increasing the steric bulk of the ancillary ligands using Ti(DMP)(4) and [Tl(mu-DMP)](infinity) led to the formation of [Tl(+)][(-)(eta(2-3)-DMP)Ti(DMP)(4)] (7). The Ti metal center is in a TBP geometry, and the "naked" Tl cation resides unencumbered by solvent molecules but was found to have a strong pi-interaction with four DMP ligands of neighboring Ti(DMP)(5)(-) anions. For this novel set of compounds, (205)Tl NMR spectroscopy was used to investigate the solution behavior of these compounds. Multiple (205)Tl resonances were observed for the solution spectra of the crystalline material of 1-6, and a broad singlet was observed for 7. The large number of minor resonances noted for these compounds was attributed to sensitivity of the Tl cation based on small variations due to ligand rearrangement. However, the major resonance noted in the (205)Tl NMR solution spectra of 1-7 are in agreement with their respective solid-state structures.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Timothy J Boyle, Cecilia A Zechmann, Todd M Alam, Mark A Rodriguez, Cybele A Hijar, Brian L Scott. 2002-02-25. From clusters to ionic complexes: structurally characterized thallium titanium double alkoxides.. https://doi.org/10.1021/ic0110833

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗